Geron Corporation (GERN)

NASDAQ HEALTHCARE
$1.54 +1.99% RSI 44 Neutral Add Alert

Moving Averages

SMA 200
$1.38
Price above

Company Profile

Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.07B
P/E Ratio
None
EPS
$-0.13
Beta
0.671
Dividend Yield
0.00%
52-Week High
$2.01
52-Week Low
$1.04

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 11:55 AM EDT

Track GERN for free

Get e-mail RSI alerts when Geron Corporation enters oversold or overbought territory. Free forever.

Add Alert